Epidemiolgy of drug resistance: The case of Staphylococcus aureus and coagulase-negative staphylococci infections

Salud Publica de Mexico

Volumn 44, Issue 2, 2002, Pages 108-112

  Calderón Jaimes, Ernesto ^a   Espinosa De Los Monteros, Luz E ^a   Avila Beltrán, Renata ^a  

^a HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

Author keywords

Antimicrobial susceptibility; Coagulase negative Staphylococcus; Drug resistance, microbial; Methicillin resistant staphylococci; Mexico; Staphylococcus aureus

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFALOTIN; CEFEPIME; CEFTRIAXONE; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; DALFOPRISTIN; DALFOPRISTIN PLUS QUINUPRISTIN; DICLOXACILLIN; EPEREZOLID; GENTAMICIN; GLYCOPEPTIDE; IMIPENEM; LINEZOLID; METICILLIN; OXACILLIN; OXAZOLIDINONE DERIVATIVE; PENICILLIN DERIVATIVE; PNU 1000766; QUINUPRISTIN; TEICOPLANIN; TIMENTIN; UNCLASSIFIED DRUG; VANCOMYCIN; COAGULASE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; COAGULASE NEGATIVE STAPHYLOCOCCUS; EPIDEMIOLOGICAL DATA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; CLINICAL TRIAL; CROSS INFECTION; DRUG EFFECT; ENZYMOLOGY; HUMAN; MICROBIOLOGY; MULTICENTER STUDY; SPECIES DIFFERENCE; STAPHYLOCOCCUS;

COAGULASE; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; HUMANS; SPECIES SPECIFICITY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 0035983923     PISSN: 00363634     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0036-36342002000200004     Document Type: Article

References (23)

1. Staphylococcus aureus infection
2. Staphylococcus aureus: A well-armed pathogen
3. Risk factors for mortality in Staphylococcus oureus bacteremia
4. Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus
5. The current spectrum of Staphylococcus aureus infection in a tertiary care hospital
6. Gram-positive organisms and sepsis
7. Antibiotic resistance in gram-positive bacteria: Epidemiologic aspects
8. Update on clinical significance of coagulase-negative staphylococci
9. The origin of coagulase-negative staphylococci isolated from blood cultures
10. Staphylococcus epidermidis: Emerging resistance and need for alternative agents
11. Coagulase-negative staphylococci: Pathogens associated with medical progress
12. New resistance in Staphylococcus aureus
13. Methicillin resistance in staphylococci. Molecular and biochemical basis and clinical implications
14. Survey of bloodstream infections due to gram-positive cocci: Frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America for the SENTRY antimicrobial surveillance program
15. Emergence of vancomycin resistance in coagulase-negative staphylococci
16. Staphylococcus and Micrococcus
17. An overview of nosocomial infections, including the role of the microbiology laboratory
18. Surveillance of antimicrobial use and antimicrobial resistance in the United States hospitals: Project ICARE phase 2
19. In vitro activity of RP59500 a new semisynthetic antibiotic, against gram-positive bacteria
20. Randomized comparison of Linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections